O2h and Hypoxium Announce an Agreement to Offer Hypoxium#39;s … – MarketWatch

table border=0 cellpadding=2 cellspacing=7 style=vertical-align:top;trtd width=80 align=center valign=topfont style=font-size:85%;font-family:arial,sans-serif/font/tdtd valign=top class=jfont style=font-size:85%;font-family:arial,sans-serifbr /div style=padding-top:0.8em;img alt= height=1 width=1 //divdiv class=lha href=http://news.google.com/news/url?fd=Ramp;sa=Tamp;url=http://www.marketwatch.com/story/o2h-and-hypoxium-announce-an-agreement-to-offer-hypoxiums-specialised-in-vitro-cell-based-oncology-assays-via-o2hs-biology-affiliate-programamp;usg=AFQjCNEw3HYJ8rwsEzZvn5zeLczupBYbrwbO2h and Hypoxium Announce an Agreement to Offer Hypoxium#39;s b…/b/b/abr /font size=-1bfont color=#6f6f6fMarketWatch/font/b/fontbr /font size=-1O2h announces the first of its Biology bAffiliate/b Partnership with Hypoxium Ltd. UK. Hypoxium has specialist capabilities in in vitro, cell-based oncology b…/b/fontbr /font size=-1 class=p/fontbr /font class=p size=-1a class=p href=http://news.google.com/news/more?pz=1amp;ned=usamp;ncl=dDUM7I36vAqVK6Mnobrband morenbsp;raquo;/b/nobr/a/font/div/font/td/tr/table

More: continued here